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"Performed the experiments: E.G., A.H., C.B., A.C., K.P., M.M., C.C., M.D., P.D. and M.J.W. Contributed reagent/ materials: J.C.S. and R.C.F., OCCAMS Contributed with analysis tools: E.G., E.B., J.C.S., M.R.Z., A.D.S. and R.C. The outcome of this analysis differs slightly from the one reported in the Article.
In Materials and Methods section, under the subheading "ATAC-seq data analysis", "A 500 bp window around the summit of the top 50,000 regions identified by MACS2 were analysed for differential accessibility using Cufflinks 25 . Normalised cleavage events across the differentially accessible regions were then counted using HOMER 38 . Heatmaps were ploted with the tool GENE-E (BROAD Institute) De novo motif discovery was carried out in HOMER 38 with flag -cpg for background normalisation. Data are deposited with ArrayExpress (Accession number E-MTAB-4209). "
should read:
"A 500 bp window around the summit of the top 50,000 regions identified by MACS2 were analysed for differential accessibility using Cufflinks
25
. Regions that showed a significant (p < 0.05) linear 5 fold change in ATAC-seq signal were taken forward for further analyses. Normalised cleavage events across the differentially accessible regions were then counted using HOMER 38 . Heatmaps were ploted with the tool GENE-E (BROAD Institute). (Fig. 4d, top) . In contrast, in chromatin regions showing reduced accessibility in MFD-1 cells and hence potentially lower activity, a different set of motifs were identified with AP-1 figuring most prominently among these (Fig. 4d, bottom) . Thus regulatory events controlled by different transcription factors are likely important determinants of the gene expression programmes in MFD-1 and HET1A cells. Interestingly, Gene Ontology analysis of the genes associated with the regulatory regions exhibiting differential accessibility (either increased or decreased) in MFD-1 cells showed enrichments for a large number of terms associated with cancer, including several epithelial cancers and GI tract neoplasms (Fig. 4e) . " prominently among these (Figure 4d, bottom) . 
